RXO
$16.54
Revenue | $1419Mn |
Net Profits | $-9Mn |
Net Profit Margins | -0.63% |
Rxo Inc’s revenue jumped 52.58% since last year same period to $1419Mn in the Q2 2025. On a quarterly growth basis, Rxo Inc has generated -0.98% fall in its revenue since last 3-months.
Rxo Inc’s net profit fell -28.57% since last year same period to $-9Mn in the Q2 2025. On a quarterly growth basis, Rxo Inc has generated 70.97% jump in its net profits since last 3-months.
Rxo Inc’s net profit margin jumped 15.74% since last year same period to -0.63% in the Q2 2025. On a quarterly growth basis, Rxo Inc has generated 70.68% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | 0.05 |
EPS Estimate Current Year | 0.05 |
Rxo Inc’s earning per share (EPS) estimates for the current quarter stand at 0.05 - a 66.67% jump from last quarter’s estimates.
Rxo Inc’s earning per share (EPS) estimates for the current year stand at 0.05.
Earning Per Share (EPS) | 0 |
Rxo Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Rxo Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2025-05-07 | -0.02 | -0.03 | -50% |
2025-11-06 | 0.05 | 0 | -100% |
2025-08-07 | 0.03 | 0.04 | 33.33% |